Yanping L. Li

No.1166 Liutai Avenue
Chengdu, 611137, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 91 publications

MANF attenuates cholestatic liver injury by enhancing GRP78-PERK interaction.

MANF attenuates cholestatic liver injury by enhancing GRP78-PERK interaction.

Journal: Biochemical pharmacology

Published: August 20, 2026

Correction: SKLB023 as an iNOS inhibitor alleviated liver fibrosis by inhibiting the TGF-beta/Smad signaling pathway.

Correction: SKLB023 as an iNOS inhibitor alleviated liver fibrosis by inhibiting the TGF-beta/Smad signaling pathway.

Journal: RSC advances

Published: July 21, 2026

Molecular fingerprinting of biodegradable poly(butylene adipate-co-terephthalate) leaching and toxic effects on coastal phytoplankton.

Molecular fingerprinting of biodegradable poly(butylene adipate-co-terephthalate) leaching and toxic effects on coastal phytoplankton.

Journal: Water research

Published: May 21, 2026

GLYAT deficiency protects against acetaminophen-induced liver injury by increasing glycine availability for glutathione synthesis.

GLYAT deficiency protects against acetaminophen-induced liver injury by increasing glycine availability for glutathione synthesis.

Journal: Biochemical pharmacology

Published: May 12, 2026

Breaking barriers: nano-boosted drug delivery systems in overcoming the defenses of pancreatic cancer.

Breaking barriers: nano-boosted drug delivery systems in overcoming the defenses of pancreatic cancer.

Journal: Molecular cancer

Published: March 25, 2026

Chondroitin Sulfate-Based ROS-Responsive Nanoparticles Targeting Activated Myofibroblasts via CD44 Receptors for the Renal Fibrosis Therapy.

Chondroitin Sulfate-Based ROS-Responsive Nanoparticles Targeting Activated Myofibroblasts via CD44 Receptors for the Renal Fibrosis Therapy.

Journal: Molecular pharmaceutics

Published: January 30, 2026

Targeting THR-β for MASLD Treatment: Current Progression and Emerging Prospects.

Targeting THR-β for MASLD Treatment: Current Progression and Emerging Prospects.

Journal: Journal of medicinal chemistry

Published: January 06, 2026

Neuroplastin-55 is a receptor of Manf and protects against diet-induced obesity by promoting adipose browning.

Neuroplastin-55 is a receptor of Manf and protects against diet-induced obesity by promoting adipose browning.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 24, 2025

A two-pronged nanomedicine counteracts obesity by remodeling adipose niche.

A two-pronged nanomedicine counteracts obesity by remodeling adipose niche.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: September 16, 2025

TOX3 in hypothalamic POMC-lineage cells regulates energy balance via the PTEN-AKT signaling axis.

TOX3 in hypothalamic POMC-lineage cells regulates energy balance via the PTEN-AKT signaling axis.

Journal: Nature communications

Published: September 05, 2025

Imidazole propionate: Cause and cure in atherosclerosis?

Imidazole propionate: Cause and cure in atherosclerosis?

Journal: Cell metabolism

Published: August 07, 2025

Artesunate modulates the tumor microenvironment via STAT1/IRF1-mediated TAM repolarization and T cell activation in non-small cell lung cancer.

Artesunate modulates the tumor microenvironment via STAT1/IRF1-mediated TAM repolarization and T cell activation in non-small cell lung cancer.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: May 19, 2025

Showing 1-12 of 91

Last Updated: 09/26/2026